Call  +41 61 926 6040
Fax +41 61 926 6049
Toggle Nav
My Cart
Search
Advanced Search
Account
Settings

Cancer

Toggle Nav

Items 11-17 of 17

Page
per page
Set Descending Direction
  1. anti-CD152 (human), mAb (ANC152.2/8H5) (preservative free)
    ANC-359-820.
    ANC-359-820100 µg
    CHF 306.00
    Add to Compare
    Learn More
  2. anti-CD152 (human), mAb (ANC152.2/8H5) (R-PE)
    ANC-359-050.
    ANC-359-050120 tests
    CHF 455.00
    Add to Compare
    Learn More
  3. anti-CD40L (human), mAb (rec.) (blocking) (hu5c8) (preservative free)
    AG-27B-6002PF
    AG-27B-6002PF-C100100 µg
    CHF 480.00
    Add to Compare
    Learn More
  4. anti-Collagen Type 1 (3/4 fragment), pAb
    AG-25T-0116
    AG-25T-0116-C02525 µg
    CHF 910.00
    Add to Compare
    Learn More
    Immunocytochemical staining of collagen degradation by human MDA-MB-231 breast cancer cells embedded in a 3D typeI collagen matrix using anti-Collagen Type 1 (¾ fragment), pAb (Prod. No. AG-25T-0116). Cells have been treated with non-targeting siRNA(A) o
  5. anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
    AG-20B-6001YPF
    AG-20B-6001YPF-C100100 µg
    CHF 290.00
    AG-20B-6001YPF-C500500 µg
    CHF 730.00
    Replaces AG-20B-6001PF
    Add to Compare
    Learn More
    anti-Fibronectin (EDA), mAb (blocking) (IST-9) (preservative free)
  6. anti-Tubulin (glycylated), pAb (Gly-pep1)
    AG-25B-0034
    AG-25B-0034-C100100 µg
    CHF 440.00
    Add to Compare
    Learn More
    Immunoblot analysis of protein glycylation using anti-Tubulin (glycylated), pAb (Gly-pep1) (Prod. No. AG-25B-0034). Method: HEK-293T cells are grown in standard culture conditions, transfected with plasmids expressing the glycylases TTLL3 and TTLL8
  7. FNDC4 (human) ELISA Kit
    AG-45B-0028
    AG-45B-0028-KI0196 wells
    CHF 610.00
    Manual
    Add to Compare
    Learn More
    FNDC4 (human) ELISA Kit

Items 11-17 of 17

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.